İçeriğe geç
Global sound
BioSpace

BioSpace

FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival

· 22 dk

Bölüm notları

The FDA held a public forum on Monday to discuss the future of psychedelic therapeutics, followed by a meeting on Wednesday regarding recommendations for reauthorizing the Prescription Drug User Fee Act the day after launching its TrialBlazer initiative. Meanwhile, Definium Therapeutics notched another late-stage trial win for its LSD drug, and Novartis continues to reel from the company’s triple asset stumble.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio Activa 91.9 FMDinlemeye devam et